Transient receptor potential ankyrin 1 (TRPA1) channel activation by the thienopyridine-type drugs ticlopidine, clopidogrel, and prasugrel

Cell Calcium

Volumn 55, Issue 4, 2014, Pages 200-207

  Schulze, Anja ^a   Hartung, Philipp ^a   Schaefer, Michael ^a   Hill, Kerstin ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Clopidogrel; Prasugrel; QGP 1; Serotonin; Thienopyridine; Ticlopidine; TRPA1

Indexed keywords

CLOPIDOGREL; PRASUGREL; THIENOPYRIDINE DERIVATIVE; TICLOPIDINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL A1; ANTITHROMBOCYTIC AGENT; CALCIUM; CALCIUM CHANNEL; NERVE PROTEIN; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN; THIOPHENE DERIVATIVE; TRANSIENT RECEPTOR POTENTIAL CHANNEL; TRPA1 PROTEIN, HUMAN;

ARTICLE; CALCIUM TRANSPORT; CHANNEL GATING; CONTROLLED STUDY; ENTEROCHROMAFFIN LIKE CELL; HEK293 CELL LINE; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SEROTONIN RELEASE; ANALOGS AND DERIVATIVES; CELL LINE; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MUTATION; SECRETION (PROCESS); TIME LAPSE IMAGING;

ANIMALIA;

CALCIUM; CALCIUM CHANNELS; CELL LINE; ENTEROCHROMAFFIN-LIKE CELLS; GENE EXPRESSION REGULATION; HEK293 CELLS; HUMANS; MUTATION; NERVE TISSUE PROTEINS; PIPERAZINES; PLATELET AGGREGATION INHIBITORS; PYRIDINES; SEROTONIN; THIOPHENES; TICLOPIDINE; TIME-LAPSE IMAGING; TRANSIENT RECEPTOR POTENTIAL CHANNELS;

EID: 84899968380     PISSN: 01434160     EISSN: 15321991     Source Type: Journal    
DOI: 10.1016/j.ceca.2014.02.014     Document Type: Article

References (50)

1. Savi P., Herbert J.M., Pflieger A.M., et al. Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel. Biochem. Pharmacol. 1992, 44:527-532.
2. Savi P., Zachayus J.-L., Delesque-Touchard N., et al. The active metabolite of Clopidogrel disrupts P2Y12 receptor oligomers and partitions them out of lipid rafts. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:11069-11074.
3. Wallentin L. P2Y(12) inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use. Eur. Heart J. 2009, 30:1964-1977.
4. Quinn M.J., Fitzgerald D.J. Ticlopidine and clopidogrel. Circulation 1999, 100:1667-1672.
5. Ito M.K., Smith A.R., Lee M.L. Ticlopidine: a new platelet aggregation inhibitor. Clin. Pharm. 1992, 11:603-617.
6. Gershon M.D., Tack J. The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007, 132:397-414.
7. Gershon M.D. Plasticity in serotonin control mechanisms in the gut. Curr. Opin. Pharmacol. 2003, 3:600-607.
8. Spiller R. Recent advances in understanding the role of serotonin in gastrointestinal motility in functional bowel disorders: alterations in 5-HT signalling and metabolism in human disease. Neurogastroenterol. Motil. 2007, 19(Suppl 2):25-31.
9. Andrews P.L., Davis C.J., Bingham S., Davidson H.I., Hawthorn J., Maskell L. The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticity. Can. J. Physiol. Pharmacol. 1990, 68:325-345.
10. Wood G.J., Shega J.W., Lynch B., von Roenn J.H. Management of intractable nausea and vomiting in patients at the end of life: I was feeling nauseous all of the time...nothing was working. JAMA 2007, 298:1196-1207.
11. Bautista D.M., Movahed P., Hinman A., et al. Pungent products from garlic activate the sensory ion channel TRPA1. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12248-12252.
12. Schulze A., Oehler B., Urban N., Schaefer M., Hill K. Apomorphine is a bimodal modulator of TRPA1 channels. Mol. Pharmacol. 2013, 83:542-551.
13. Karashima Y., Damann N., Prenen J., et al. Bimodal action of menthol on the transient receptor potential channel TRPA1. J. Neurosci. 2007, 27:9874-9884.
14. Vilceanu D., Stucky C.L. TRPA1 mediates mechanical currents in the plasma membrane of mouse sensory neurons. PLoS ONE 2010, 5:e12177.
15. Baraldi P.G., Preti D., Materazzi S., Geppetti P. Transient receptor potential ankyrin 1 (TRPA1) channel as emerging target for novel analgesics and anti-inflammatory agents. J. Med. Chem. 2010, 53:5085-5107.
16. Meseguer V., Karashima Y., Talavera K., et al. Transient receptor potential channels in sensory neurons are targets of the antimycotic agent clotrimazole. J. Neurosci. 2008, 28:576-586.
17. Bandell M., Story G.M., Hwang S.W., et al. Noxious cold ion channel TRPA1 is activated by pungent compounds and bradykinin. Neuron 2004, 41:849-857.
18. Nagata K., Duggan A., Kumar G., García-Añoveros J. Nociceptor and hair cell transducer properties of TRPA1, a channel for pain and hearing. J. Neurosci. 2005, 25:4052-4061.
19. Brierley S.M., Hughes P.A., Page A.J., et al. The ion channel TRPA1 is required for normal mechanosensation and is modulated by algesic stimuli. Gastroenterology 2009, 137:2084-2095. e3.
20. Cattaruzza F., Johnson C., Leggit A., et al. Transient receptor potential ankyrin 1 mediates chronic pancreatitis pain in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 2013, 304:G1002-G1012.
21. Kondo T., Oshima T., Obata K., et al. Role of transient receptor potential A1 in gastric nociception. Digestion 2010, 82:150-155.
22. Penuelas A., Tashima K., Tsuchiya S., et al. Contractile effect of TRPA1 receptor agonists in the isolated mouse intestine. Eur. J. Pharmacol. 2007, 576:143-150.
23. Zhang L., Jones S., Brody K., Costa M., Brookes S.J.H. Thermosensitive transient receptor potential channels in vagal afferent neurons of the mouse. Am. J. Physiol. Gastrointest. Liver Physiol. 2004, 286:G983-G991.
24. Poole D.P., Pelayo J.C., Cattaruzza F., et al. Transient receptor potential ankyrin 1 is expressed by inhibitory motoneurons of the mouse intestine. Gastroenterology 2011, 141:565-575. 575.e1-4.
25. Holzer P. Transient receptor potential (TRP) channels as drug targets for diseases of the digestive system. Pharmacol. Ther. 2011, 131:142-170.
26. Purhonen A.K., Louhivuori L.M., Kiehne K., Kerman K.E.O., Herzig K.H. TRPA1 channel activation induces cholecystokinin release via extracellular calcium. FEBS Lett. 2008, 582:229-232.
27. Nozawa K., Kawabata-Shoda E., Doihara H., et al. TRPA1 regulates gastrointestinal motility through serotonin release from enterochromaffin cells. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:3408-3413.
28. Doihara H., Nozawa K., Kawabata-Shoda E., Kojima R., Yokoyama T., Ito H. Molecular cloning and characterization of dog TRPA1 and AITC stimulate the gastrointestinal motility through TRPA1 in conscious dogs. Eur. J. Pharmacol. 2009, 617:124-129.
29. Capasso R., Aviello G., Romano B., et al. Modulation of mouse gastrointestinal motility by allyl isothiocyanate, a constituent of cruciferous vegetables (Brassicaceae): evidence for TRPA1-independent effects. Br. J. Pharmacol. 2012, 165:1966-1977.
30. Hill K., Schaefer M. TRPA1 is differentially modulated by the amphipathic molecules trinitrophenol and chlorpromazine. J. Biol. Chem. 2007, 282:7145-7153.
31. 2+-controlled competitive diacylglycerol binding of protein kinase C isoenzymes in living cells. J. Cell Biol. 2002, 159:291-302.
32. Nörenberg W., Sobottka H., Hempel C., et al. Positive allosteric modulation by ivermectin of human but not murine P2X7 receptors. Br. J. Pharmacol. 2012, 167:48-66.
33. McNamara C.R., Mandel-Brehm J., Bautista D.M., et al. TRPA1 mediates formalin-induced pain. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:13525-13530.
34. Eid S.R., Crown E.D., Moore E.L., et al. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity. Mol. Pain 2008, 4:48.
35. Wang Y.Y., Chang R.B., Waters H.N., McKemy D.D., Liman E.R. The nociceptor ion channel TRPA1 is potentiated and inactivated by permeating calcium ions. J. Biol. Chem. 2008, 283:32691-32703.
36. Doerner J.F., Gisselmann G., Hatt H., Wetzel C.H. Transient receptor potential channel A1 is directly gated by calcium ions. J. Biol. Chem. 2007, 282:13180-13189.
37. Hinman A., Chuang H.-H., Bautista D.M., Julius D. TRP channel activation by reversible covalent modification. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:19564-19568.
38. Ibarra Y., Blair N.T. Benzoquinone reveals a cysteine-dependent desensitization mechanism of TRPA1. Mol. Pharmacol. 2013, 83:1120-1132.
39. Doihara H., Nozawa K., Kojima R., Kawabata-Shoda E., Yokoyama T., Ito H. QGP-1 cells release 5-HT via TRPA1 activation; a model of human enterochromaffin cells. Mol. Cell. Biochem. 2009, 331:239-245.
40. Chen J., Joshi S.K., DiDomenico S., et al. Selective blockade of TRPA1 channel attenuates pathological pain without altering noxious cold sensation or body temperature regulation. Pain 2011, 152:1165-1172.
41. Talavera K., Gees M., Karashima Y., et al. Nicotine activates the chemosensory cation channel TRPA1. Nat. Neurosci. 2009, 12:1293-1299.
42. Macpherson L.J., Dubin A.E., Evans M.J., et al. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 2007, 445:541-545.
43. Freeman S.L., Bohan D., Darcel N., Raybould H.E. Luminal glucose sensing in the rat intestine has characteristics of a sodium-glucose cotransporter. Am. J. Physiol. Gastrointest. Liver Physiol. 2006, 291:G439-G445.
44. Zhu J.X., Zhu X.Y., Owyang C., Li Y. Intestinal serotonin acts as a paracrine substance to mediate vagal signal transmission evoked by luminal factors in the rat. J. Physiol. (Lond.) 2001, 530:431-442.
45. Racké K., Schwörer H. Characterization of the role of calcium and sodium channels in the stimulus secretion coupling of 5-hydroxytryptamine release from porcine enterochromaffin cells. Naunyn. Schmiedebergs Arch. Pharmacol. 1993, 347:1-8.
46. Alpizar Y.A., Sanchez A., Radwan A., Radwan I., Voets T., Talavera K. Lack of correlation between the amplitudes of TRP channel-mediated responses to weak and strong stimuli in intracellular Ca(2+) imaging experiments. Cell Calcium; 2013, 54:362-374.
47. 2+. Nat. Neurosci. 2007, 10:277-279.
48. Chen J., Kim D., Bianchi B.R., et al. Pore dilation occurs in TRPA1 but not in TRPM8 channels. Mol. Pain 2009, 5:3.
49. Kurogi M., Miyashita M., Emoto Y., Kubo Y., Saitoh O. Green tea polyphenol epigallocatechin gallate activates TRPA1 in an intestinal enteroendocrine cell line, STC-1. Chem. Senses 2012, 37:167-177.
50. Chua A.S., Dinan T.G., Rovati L.C., Keeling P.W. Cholecystokinin hyperresponsiveness in dysmotility-type nonulcer dyspepsia. Ann. N. Y. Acad. Sci. 1994, 713:298-299.